{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T07:05:29Z","timestamp":1777878329924,"version":"3.51.4"},"reference-count":44,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T00:00:00Z","timestamp":1742601600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T00:00:00Z","timestamp":1742601600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Advances in Hematology"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is crucial for treating high-risk hematological cancers. Posttransplant infections are a leading cause of mortality and morbidity, especially before engraftment. This study evaluated the effects of granulocyte transfusion (GT) therapy on neutrophil and platelet (PLT) engraftment in patients with febrile neutropenia during the pre-engraftment phase following allo-HSCT with a control group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We retrospectively analyzed 56 patients who underwent allo-HSCT from January 2019 to January 2024, dividing them into two groups: those who received GT (GTG) and those who did not (non-GTG).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of 76 GTs were administered to 28 patients with febrile neutropenia during the pre-engraftment period. The median granulocyte dose was 5.4 \u00d7 10\n                      <jats:sup>8<\/jats:sup>\n                      \/kg. Median engraftment times in the GTG were 13 days for both PLT and neutrophil engraftment, compared to 15.5 days (PLT) and 19 days (neutrophil) in the non-GTG (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.001 for neutrophil and\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.007 for PLT). Additionally, 89.3% of patients in the GTG showed improved infection status. Overall survival (OS) at 2 year was 61.4% for GTG and 73.2% for non-GTG, respectively. No significant difference in OS between the groups (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &gt; 0.05). In the non-GTG, the OS rate was 47.5%, with no significant difference in OS and mortality rates between the groups. GT did not affect the incidence of graft-versus-host disease or cytomegalovirus infection.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This study is the first to include a control group and demonstrate a statistically significant association between GT therapy in the pre-engraftment period and shortened engraftment times in allo-HSCT recipients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/20406207251326765","type":"journal-article","created":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T07:49:45Z","timestamp":1742629785000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Effective engraftment via granulocyte transfusion in pre-engraftment febrile neutropenia following allogeneic hematopoietic stem cell transplantation: granulocyte transfusion as bridge therapy"],"prefix":"10.1177","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6298-9884","authenticated-orcid":false,"given":"Neslihan","family":"Mandaci \u015eanli","sequence":"first","affiliation":[{"name":"Department of Hematology and Bone Marrow Transplant Center, Erciyes University Faculty of Medicine, Kayseri 38039, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"\u00dcnal","sequence":"additional","affiliation":[{"name":"Department of Hematology and Bone Marrow Transplant Center, Erciyes University Faculty of Medicine, Kayseri, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2025,3,22]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-021-01159-2"},{"issue":"1","key":"e_1_3_4_3_2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1053\/j.seminhematol.2011.10.009","article-title":"Challenges to preventing infectious complications, decreasing re-hospitalizations, and reducing cost burden in long-term survivors after allogeneic hematopoietic stem cell transplantation","volume":"49","author":"Fuji S","year":"2012","unstructured":"Fuji S, Kapp M, Einsele H. Challenges to preventing infectious complications, decreasing re-hospitalizations, and reducing cost burden in long-term survivors after allogeneic hematopoietic stem cell transplantation. Semin Hematol 2012; 49(1): 10\u201314.","journal-title":"Semin Hematol"},{"issue":"1","key":"e_1_3_4_4_2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.hoc.2010.11.008","article-title":"Hematopoietic stem cell transplantation: an overview of infection risks and epidemiology","volume":"25","author":"Wingard JR","year":"2011","unstructured":"Wingard JR, Hsu J, Hiemenz JW. Hematopoietic stem cell transplantation: an overview of infection risks and epidemiology. Hematol Oncol Clin North Am 2011; 25(1): 101\u2013116.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"12","key":"e_1_3_4_5_2","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.3324\/haematol.2009.013680","article-title":"Granulocyte transfusion therapy: randomization after all?","volume":"94","author":"Dreniak A","year":"2009","unstructured":"Dreniak A, Kulipers TW. Granulocyte transfusion therapy: randomization after all? Haematologica 2009; 94(12): 1644\u20131648.","journal-title":"Haematologica"},{"issue":"2","key":"e_1_3_4_6_2","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.idc.2010.01.010","article-title":"Hematopoietic stem cell transplantation: an overview of infection risks and epidemiology","volume":"24","author":"Wingard JR","year":"2010","unstructured":"Wingard JR, Hsu J, Hiemenz JW. Hematopoietic stem cell transplantation: an overview of infection risks and epidemiology. Infect Dis Clin North Am 2010; 24(2): 257\u2013272.","journal-title":"Infect Dis Clin North Am"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2016.05.006"},{"issue":"8","key":"e_1_3_4_8_2","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1056\/NEJM197208242870801","article-title":"Normal granulocyte transfusion therapy: treatment of septicemia due to gram-negative bacteria","volume":"287","author":"Graw RG","year":"1972","unstructured":"Graw RGJr, Herzig G, Perry S, et al. Normal granulocyte transfusion therapy: treatment of septicemia due to gram-negative bacteria. N Engl J Med 1972; 287(8): 367\u2013371.","journal-title":"N Engl J Med"},{"issue":"11","key":"e_1_3_4_9_2","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1111\/j.1537-2995.2006.00996.x","article-title":"Safety and efficacy of therapeutic early onset granulocyte transfusions in pediatric patients with neutropenia and severe infections","volume":"46","author":"Sachs UJ","year":"2006","unstructured":"Sachs UJ, Reiter A, Walter T, et al. Safety and efficacy of therapeutic early onset granulocyte transfusions in pediatric patients with neutropenia and severe infections. Transfusion 2006; 46(11): 1909\u20131914.","journal-title":"Transfusion"},{"issue":"12","key":"e_1_3_4_10_2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0209832","article-title":"Role of granulocyte transfusions in combating life-threatening infections in patients with severe neutropenia: experience from a tertiary care centre in North India","volume":"13","author":"Garg A","year":"2018","unstructured":"Garg A, Gupta A, Mishra A, et al. Role of granulocyte transfusions in combating life-threatening infections in patients with severe neutropenia: experience from a tertiary care centre in North India. PLoS One 2018; 13(12): e0209832.","journal-title":"PLoS One"},{"issue":"11","key":"e_1_3_4_11_2","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1007\/s00277-018-3432-4","article-title":"Clinical outcome of granulocyte transfusion therapy for the treatment of refractory infection in neutropenic patients with hematological diseases","volume":"97","author":"Zhou B","year":"2018","unstructured":"Zhou B, Song T, Feng Y, et al. Clinical outcome of granulocyte transfusion therapy for the treatment of refractory infection in neutropenic patients with hematological diseases. Ann Hematol 2018; 97(11): 2061\u20132070.","journal-title":"Ann Hematol"},{"issue":"10","key":"e_1_3_4_12_2","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/s00431-016-2774-y","article-title":"Granulocyte transfusions in critically ill children with prolonged neutropenia: side effects and survival rates from a single-center analysis","volume":"175","author":"Weingarten C","year":"2016","unstructured":"Weingarten C, Pliez S, Tschiedel E, et al. Granulocyte transfusions in critically ill children with prolonged neutropenia: side effects and survival rates from a single-center analysis. Eur J Pediatr 2016; 175(10): 1361\u20131369.","journal-title":"Eur J Pediatr"},{"key":"e_1_3_4_13_2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.21037\/aob-21-46","article-title":"Granulocyte transfusion therapy","volume":"7","author":"Tanhehco YC","year":"2022","unstructured":"Tanhehco YC. Granulocyte transfusion therapy. Ann Blood 2022; 7: 5.","journal-title":"Ann Blood"},{"issue":"6","key":"e_1_3_4_14_2","doi-asserted-by":"crossref","first-page":"103453","DOI":"10.1016\/j.transci.2022.103453","article-title":"Successful neutrophil engraftment supported by granulocyte transfusion in adult allogeneic transplant patients with peri-transplant active infection","volume":"61","author":"Ikegawa S","year":"2022","unstructured":"Ikegawa S, Fujii N, Fujii K, et al. Successful neutrophil engraftment supported by granulocyte transfusion in adult allogeneic transplant patients with peri-transplant active infection. Transfus Apher Sci 2022; 61(6): 103453.","journal-title":"Transfus Apher Sci"},{"issue":"11","key":"e_1_3_4_15_2","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V95.11.3302.010k35_3302_3309","article-title":"Phase I\/II trial of neutrophil transfusions from donors stimulated with G-CSF and dexamethasone for treatment of patients with infections in hematopoietic stem cell transplantation","volume":"95","author":"Price TH","year":"2000","unstructured":"Price TH, Bowden RA, Boeckh M, et al. Phase I\/II trial of neutrophil transfusions from donors stimulated with G-CSF and dexamethasone for treatment of patients with infections in hematopoietic stem cell transplantation. Blood 2000; 95(11):3302\u20139.","journal-title":"Blood"},{"issue":"6","key":"e_1_3_4_16_2","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/bmt.2015.53","article-title":"Single-donor granulocyte transfusions for improving the outcome of high-risk pediatric patients with known bacterial and fungal infections undergoing stem cell transplantation: a 10-year single-center experience","volume":"50","author":"Nikolajeva O","year":"2015","unstructured":"Nikolajeva O, Mijovic A, Hess D, et al. Single-donor granulocyte transfusions for improving the outcome of high-risk pediatric patients with known bacterial and fungal infections undergoing stem cell transplantation: a 10-year single-center experience. Bone Marrow Transplant 2015; 50(6): 846\u2013849.","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"e_1_3_4_17_2","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1182\/blood-2011-10-345751","article-title":"Blood consult: granulocyte transfusions to treat invasive aspergillosis in a patient with severe aplastic anemia awaiting mismatched hematopoietic progenitor cell transplantation","volume":"119","author":"O\u2019Donghaile D","year":"2012","unstructured":"O\u2019Donghaile D, Childs RW, Leitman SF. Blood consult: granulocyte transfusions to treat invasive aspergillosis in a patient with severe aplastic anemia awaiting mismatched hematopoietic progenitor cell transplantation. Blood 2012; 119(6): 1353\u20131355.","journal-title":"Blood"},{"issue":"11","key":"e_1_3_4_18_2","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1182\/blood.V95.11.3605","article-title":"Effect of leukocyte compatibility on neutrophil increment after transfusion of granulocyte colony-stimulating factor-mobilized prophylactic granulocyte transfusions and on clinical outcomes after stem cell transplantation","volume":"95","author":"Adkins DR","year":"2000","unstructured":"Adkins DR, Goodnough LT, Shenoy S, et al. Effect of leukocyte compatibility on neutrophil increment after transfusion of granulocyte colony-stimulating factor-mobilized prophylactic granulocyte transfusions and on clinical outcomes after stem cell transplantation. Blood 2000; 95(11): 3605\u20133612.","journal-title":"Blood"},{"issue":"7","key":"e_1_3_4_19_2","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1046\/j.1537-2995.1997.37797369451.x","article-title":"Transfusions of granulocyte-colony-stimulating factor-mobilized granulocyte components to allogeneic transplant recipients: analysis of kinetics and factors determining posttransfusion neutrophil and platelet counts","volume":"37","author":"Adkins D","year":"1997","unstructured":"Adkins D, Spitzer G, Johnston M, et al. Transfusions of granulocyte-colony-stimulating factor-mobilized granulocyte components to allogeneic transplant recipients: analysis of kinetics and factors determining posttransfusion neutrophil and platelet counts. Transfusion 1997; 37(7): 737\u2013748.","journal-title":"Transfusion"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-017-4683-6"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1086\/599376"},{"key":"e_1_3_4_22_2","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/cid\/ciw504","article-title":"Management of adults with hospital-acquired and ventilator-associated pneumo nia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society","volume":"63","author":"Kalil AC","year":"2016","unstructured":"Kalil AC, Metersky ML, Klompas M, et al. Management of adults with hospital-acquired and ventilator-associated pneumo nia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis 2016; 63: 575\u2013582.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"e_1_3_4_23_2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.transci.2018.04.014","article-title":"Graft failure after allogeneic hematopoietic stem cell transplantation","volume":"57","author":"Ozdemir ZN","year":"2018","unstructured":"Ozdemir ZN, Civriz Bozda\u011f S. Graft failure after allogeneic hematopoietic stem cell transplantation. Transfus Apher Sci 2018; 57(2): 163\u2013167.","journal-title":"Transfus Apher Sci"},{"issue":"5","key":"e_1_3_4_24_2","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1182\/blood.V100.5.1860.h81702001860_1860_1868","article-title":"Role of toll-like receptor 2 (TLR2) in neutrophil activation: GM-CSF enhances TLR2 expression and TLR2-mediated interleukin-8 responses in neutrophils","volume":"100","author":"Kurt-Jones EA","year":"2002","unstructured":"Kurt-Jones EA, Mandell L, Whitney C, et al. Role of toll-like receptor 2 (TLR2) in neutrophil activation: GM-CSF enhances TLR2 expression and TLR2-mediated interleukin-8 responses in neutrophils. Blood 2002; 100(5): 1860\u20131868.","journal-title":"Blood"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2006.04.008"},{"key":"e_1_3_4_26_2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1034\/j.1600-065X.2000.17706.x","article-title":"The neutrophil is a cellular source of chemokines","volume":"177","author":"Scapini P","year":"2000","unstructured":"Scapini P, Lapinet-Vera JA, Gasperini S, et al. The neutrophil is a cellular source of chemokines. Immunol Rev 2000; 177: 195\u2013203.","journal-title":"Immunol Rev"},{"issue":"22","key":"e_1_3_4_27_2","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1182\/blood-2009-11-253245","article-title":"Toll-like receptor-induced reactivity and strongly potentiated IL-8 production in granulocytes mobilized for transfusion purposes","volume":"115","author":"Drewniak A","year":"2010","unstructured":"Drewniak A, Tool AT, Geissler J, et al. Toll-like receptor-induced reactivity and strongly potentiated IL-8 production in granulocytes mobilized for transfusion purposes. Blood 2010; 115(22): 4588\u20134596.","journal-title":"Blood"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24021010"},{"issue":"2","key":"e_1_3_4_29_2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000204114","article-title":"Effects of interleukin-1 and tumor necrosis factor on megakaryocytopoiesis: mechanism of reactive thrombocytosis","volume":"93","author":"Dan K","year":"1995","unstructured":"Dan K, Gomi S, Inokuchi K, et al. Effects of interleukin-1 and tumor necrosis factor on megakaryocytopoiesis: mechanism of reactive thrombocytosis. Acta Haematol 1995; 93(2\u20134): 67\u201372.","journal-title":"Acta Haematol"},{"issue":"6","key":"e_1_3_4_30_2","doi-asserted-by":"crossref","first-page":"867","DOI":"10.3324\/haematol.2011.053363","article-title":"Cytopenia and leukocyte recovery shape cytokine fluctuations after myeloablative allogeneic hematopoietic stem cell transplantation","volume":"97","author":"Melenhorst JJ","year":"2012","unstructured":"Melenhorst JJ, Tian X, Xu D, et al. Cytopenia and leukocyte recovery shape cytokine fluctuations after myeloablative allogeneic hematopoietic stem cell transplantation. Haematologica 2012; 97(6): 867\u2013873.","journal-title":"Haematologica"},{"key":"e_1_3_4_31_2","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1055\/s-0042-1757730","article-title":"Granulocyte transfusion therapy: institutional experience of benefit in cancer patients with prolonged neutropenic sepsis\u2014a retrospective study","volume":"43","author":"Shrivastava SP","year":"2022","unstructured":"Shrivastava SP, Prutha AE, Bansal JS, et al. Granulocyte transfusion therapy: institutional experience of benefit in cancer patients with prolonged neutropenic sepsis\u2014a retrospective study. Indian J Med Paediatr Oncol 2022; 43: 507\u2013512.","journal-title":"Indian J Med Paediatr Oncol"},{"issue":"11","key":"e_1_3_4_32_2","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1046\/j.1537-2995.2002.00249.x","article-title":"Granulocyte transfusion therapy for infections in candidates and recipients of HPC transplantation: a comparative analysis of feasibility and outcome for community donors versus related donors","volume":"42","author":"H\u00fcbel K","year":"2002","unstructured":"H\u00fcbel K, Carter RA, Liles WC, et al. Granulocyte transfusion therapy for infections in candidates and recipients of HPC transplantation: a comparative analysis of feasibility and outcome for community donors versus related donors. Transfusion 2002; 42(11): 1414\u20131421.","journal-title":"Transfusion"},{"issue":"1","key":"e_1_3_4_33_2","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1046\/j.1365-2141.2003.04583.x","article-title":"The use of stimulated granulocyte transfusions to prevent recurrence of past severe infections after allogeneic stem cell transplantation","volume":"123","author":"Kerr JP","year":"2003","unstructured":"Kerr JP, Liakopolou E, Brown J, et al. The use of stimulated granulocyte transfusions to prevent recurrence of past severe infections after allogeneic stem cell transplantation. Br J Haematol 2003; 123(1): 114\u2013118.","journal-title":"Br J Haematol"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2012.03661.x"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2017.07.029"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2017.08.012"},{"issue":"18","key":"e_1_3_4_37_2","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1182\/blood-2015-05-645986","article-title":"Efficacy of transfusion with granulocytes from G-CSF\/dexamethasone-treated donors in neutropenic patients with infection","volume":"126","author":"Price TH","year":"2015","unstructured":"Price TH, Boeckh M, Harrison RW, et al. Efficacy of transfusion with granulocytes from G-CSF\/dexamethasone-treated donors in neutropenic patients with infection. Blood 2015; 126(18): 2153\u20132161.","journal-title":"Blood"},{"issue":"5","key":"e_1_3_4_38_2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3109\/08880018.2013.868562","article-title":"Granulocyte transfusions for children with infection and neutropenia or granulocyte dysfunction","volume":"31","author":"Diaz R","year":"2014","unstructured":"Diaz R, Soundar E, Hartman SK, et al. Granulocyte transfusions for children with infection and neutropenia or granulocyte dysfunction. Pediatr Hematol Oncol 2014; 31(5): 425\u2013434.","journal-title":"Pediatr Hematol Oncol"},{"issue":"11","key":"e_1_3_4_39_2","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1007\/s00277-005-1055-z","article-title":"Prophylactic and interventional granulocyte transfusions in patients with haematological malignancies and life-threatening infections during neutropenia","volume":"84","author":"Mousset S","year":"2005","unstructured":"Mousset S, Hermann S, Klein SA, et al. Prophylactic and interventional granulocyte transfusions in patients with haematological malignancies and life-threatening infections during neutropenia. Ann Hematol 2005; 84(11): 734\u2013741.","journal-title":"Ann Hematol"},{"issue":"1","key":"e_1_3_4_40_2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-3148.2010.01035.x","article-title":"Treatment of severe neutropenic sepsis with granulocyte transfusion in the current era-experience from an adult haematology unit in Singapore","volume":"21","author":"Ang AL","year":"2011","unstructured":"Ang AL, Linn YC. Treatment of severe neutropenic sepsis with granulocyte transfusion in the current era-experience from an adult haematology unit in Singapore. Transfus Med 2011; 21(1): 13\u201324.","journal-title":"Transfus Med"},{"issue":"4","key":"e_1_3_4_41_2","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3109\/14653249.2010.529889","article-title":"Therapeutic granulocyte transfusions for the treatment of febrile neutropenia in patients with hematologic diseases: a 10-year experience at a single institute","volume":"13","author":"Kim KH","year":"2011","unstructured":"Kim KH, Lim HJ, Kim JS, et al. Therapeutic granulocyte transfusions for the treatment of febrile neutropenia in patients with hematologic diseases: a 10-year experience at a single institute. Cytotherapy 2011; 13(4): 490\u2013498.","journal-title":"Cytotherapy"},{"issue":"3","key":"e_1_3_4_42_2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/MPH.0b013e318196a6f9","article-title":"Granulocyte transfusions in children and young adults: does the dose matter?","volume":"31","author":"Seidel MG","year":"2009","unstructured":"Seidel MG, Minkov M, Witt V, et al. Granulocyte transfusions in children and young adults: does the dose matter? J Pediatr Hematol Oncol 2009; 31(3): 166\u2013172.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"2","key":"e_1_3_4_43_2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s12288-016-0727-2","article-title":"Changing trends in the use of granulocyte transfusions in neutropenic children with sepsis in India","volume":"33","author":"Uppuluri R","year":"2017","unstructured":"Uppuluri R, Ramachandrakurup S, Vaidhyanathan L, et al. Changing trends in the use of granulocyte transfusions in neutropenic children with sepsis in India. Indian J Hematol Blood Transfus 2017; 33(2): 207\u2013210.","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"12","key":"e_1_3_4_44_2","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V80.12.2964.2964","article-title":"Cytokine dysregulation and acute graft-versus-host disease","volume":"80","author":"Antin JH","year":"1992","unstructured":"Antin JH, Ferrara JL. Cytokine dysregulation and acute graft-versus-host disease. Blood 1992; 80(12): 2964.","journal-title":"Blood"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-08-551994"}],"container-title":["Therapeutic Advances in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20406207251326765","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/20406207251326765","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20406207251326765","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:17:42Z","timestamp":1777591062000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/20406207251326765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,22]]},"references-count":44,"alternative-id":["10.1177\/20406207251326765"],"URL":"https:\/\/doi.org\/10.1177\/20406207251326765","relation":{},"ISSN":["2040-6207","2040-6215"],"issn-type":[{"value":"2040-6207","type":"print"},{"value":"2040-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,22]]},"article-number":"20406207251326765"}}